Laboratory
Manual. Cold Spring Harbor Laboratory Press
(Cold Spring Harbor, NY), pp. 423-470, 513-551
(1988).
Notice
We provide information and advice to our customers
on application technologies
dioxide colloidal, highly dispersed, suitable for use as excipient EMPROVE® exp Ph Eur, NF, JP, E 551
111544 Wax white in pastilles, suitable for use as excipient EMPROVE® exp Ph Eur, BP
Preservatives
. Injury 42:556–561.
4. Marsell R, Einhorn TA (2011) The biology of fracture healing. Injury 42:551–555.
5. Muschler GF, Nakamoto C, Griffith LG (2004) Engineering principles of clinical cell-
based
dioxide colloidal, highly dispersed, suitable for use as
excipient EMPROVE® exp Ph Eur, NF, JP, E 551
EXP • • • •
137046 Sodium acetate anhydrous, suitable for the biopharmaceutical
production
phospho-PAK1 (pThr212) P3237 5058 PAK1 M NP_001122092.1 y y y
554 Parkin P6248 5071 PARK2 M NP_004553.2 y y y
551 Par-4 (Prostate Apoptosis Response-4) P5367 5074 PAWR P NP_002574.2 y y y
558 Proliferating Cell Nuclear
phospho-PAK1 (pThr212) P3237 5058 PAK1 M NP_001122092.1 y y y
554 Parkin P6248 5071 PARK2 M NP_004553.2 y y y
551 Par-4 (Prostate Apoptosis Response-4) P5367 5074 PAWR P NP_002574.2 y y y
558 Proliferating Cell Nuclear
phospho-PAK1 (pThr212) P3237 5058 PAK1 M NP_001122092.1 y y y
554 Parkin P6248 5071 PARK2 M NP_004553.2 y y y
551 Par-4 (Prostate Apoptosis Response-4) P5367 5074 PAWR P NP_002574.2 y y y
558 Proliferating Cell Nuclear
214 phospho-DAPK (pSer308) D4941 M y n/d n/d
215 DAP Kinase 2 D3191 P y y y
216 Anti Cy3+Cy5 C0992 M NA NA NA
217 Daxx D7810 P y n/d n/d
218 DcR1 D3566 P y y y
219 DcR2 D3188 P y
DAP Kinase 2 D3191 23604, 13143, 300799 DAPK2,Dapk2 NP_055141.2,NP_034149.2,NP_001013127.1 P y y y
216 Anti Cy3+Cy5
217 Daxx D7810 13163, 1616 DAXX,Daxx NP_031855.3,NP_001341.1 P y n/d n/d
218 DcR1 D3566
Kinase 2 D3191 23604, 13143, 300799 DAPK2,Dapk2 NP_055141.2,NP_034149.2,NP_001013127.1 P y y y
216 Anti Cy3+Cy5 C0992
217 Daxx D7810 13163, 1616 DAXX,Daxx NP_031855.3,NP_001341.1 P y n/d n/d
218 DcR1 D3566